PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY
العنوان: | PB1837: ADDITION OF A THIRD, NON-TARGETED, AGENT TO CYTARABINE- AND ANTHRACYCLINE-BASED INDUCTION CHEMOTHERAPY FOR ACUTE MYELOBLASTIC LEUKEMIA INCREASES COMPLETE REMISSIONS AND TREATMENT-RELATED MORTALITY |
---|---|
المؤلفون: | M. Pereira, G. Marques, A.-B. Sarmento-Ribeiro |
المصدر: | HemaSphere. 6:1717-1718 |
بيانات النشر: | Ovid Technologies (Wolters Kluwer Health), 2022. |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Hematology |
تدمد: | 2572-9241 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::4efc60e478f51379d485e65b269985f6 https://doi.org/10.1097/01.hs9.0000850200.50801.a5 |
حقوق: | OPEN |
رقم الأكسشن: | edsair.doi...........4efc60e478f51379d485e65b269985f6 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 25729241 |
---|